A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

NCT01442363 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of recruitment, discontinuation of program

Conditions

Perianal Crohn's Disease

Interventions

DRUG: BLI-1300 low dose
DRUG: BLI-1300 high dose
DRUG: placebo

Sponsor

Braintree Laboratories